SEIKAGAKU
Live / Registered — Registered — partial invalidation of extension of protection (as of 22 Dec 2021)
What this means for you
Registered since 28 Jun 2011. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79070961
- Registration number
- 3983398
- Mark type
- Design + words
- Filed
- 13 Mar 2009
- Published for opposition
- 12 Apr 2011
- Registered
- 28 Jun 2011
- Attorney of record
- Mainak H. Mehta
Goods and services
- Class 001 — Chemicals: (( [ Hyaluronic acid and salts of hyaluronic acid as raw materials for use in the production of pharmaceutical preparations, cosmetic preparations, food, nutritional supplements and biomaterials, namely, tissue-engineered products, artificial skin products, artificial vitreous body products and anti-adhesive products, and for research purposes in the biomedical field; ] )) Chondroitin sulfate and salts of chondoroitin sulfate as raw materials for use in the production of (( pharmaceutical preparations, cosmetic preparations, food, nutritional supplements and biomaterials, namely, tissue-engineered products, )) artificial skin products and corneal preservation medium, and for research purposes in the biomedical field; Chemical reagents for scientific, research and quality control purposes, namely, limulus amebocyte lysate reagents for use in analysis of endotoxins (( [ and beta-glucan; Reagents, namely, glycobiological analysis reagents for clinical and medical laboratory use, and diagnostic preparations and reagents for clinical and medical laboratory use ] ))
- Class 005 — Pharmaceuticals: (( Joint function improving agents, namely, pharmaceutical preparations for treating arthrosis and other joint diseases; [ Ophthalmic surgical aid, namely, sodium hyaluronate solution used for surgery in and around the eyes; Pharmaceutical preparations for the treatment of disc hernia; ] Syringes sold filled with pharmaceuticals, namely, crosslinked or non-crosslinked hyaluronic acid based gel for the treatment of arthrosis and osteoarthritis; Syringes sold filled with pharmaceuticals, namely, sodium hyaluronate solutions for the treatment of arthrosis and osteoarthritis )) [ ; Diagnostic preparations for medical purposes for detecting mycosis; Diagnostic preparations for medical purposes, namely, diagnostic reagents for in-vitro clinical diagnostic purposes ]
- Class 010 — Medical apparatus: [ Injection syringes ; Injection needles ]
Owner
- SEIKAGAKU CORPORATION, Tokyo, JP
- SEIKAGAKU CORPORATION, Tokyo 100-0005, JP
- SEIKAGAKU CORPORATION, Tokyo 100-0005, JP
Prosecution history
- 24 Oct 2022 — PARTIAL INVALIDATION PROCESSED BY THE IB
- 26 Sept 2022 — PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 26 Sept 2022 — INVALIDATION PROCESSED
- 22 Aug 2022 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 22 Dec 2021 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
- 22 Dec 2021 — REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
- 08 Dec 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 16 Jun 2021 — TEAS SECTION 71 & 15 RECEIVED
- 28 Jun 2020 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 28 Mar 2019 — INTERNATIONAL REGISTRATION RENEWED
- 13 Apr 2018 — PARTIAL INVALIDATION PROCESSED BY THE IB
- 08 Mar 2018 — PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 08 Mar 2018 — INVALIDATION PROCESSED
- 26 Feb 2018 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 26 Jun 2017 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED